TCL Archive In Brief: Bristol To Drop Angiostatin; Protein Fails To Meet Criteria For Development, Firm Says February 12, 1999
TCL Archive Erbitux Addition to Chemotherapy Regimen Can Make Inoperable Disease Operable April 26, 2013